Axio Bio is a leading medical technology company specializing in advanced bleeding control and wound care solutions. The company develops innovative biomaterial-based products powered by proprietary PBT® and BMG® technologies to improve patient outcomes in trauma care, surgical procedures, and chronic wound management. Its flagship products include Axiostat® hemostatic dressings for rapid bleeding control and MaxioCel® advanced wound care dressings for effective wound healing. Trusted by healthcare professionals, emergency responders, defense organizations, and hospitals worldwide, Axio Bio delivers clinically proven solutions that help save lives and enhance patient comfort. The company serves customers across more than 50 countries with FDA-cleared and internationally recognized medical products.